We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
(+48%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$55.3M |
| 2 |
Apple
AAPL
|
+$33.2M |
| 3 |
Amazon
AMZN
|
+$29.2M |
| 4 |
Microsoft
MSFT
|
+$26.4M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$93.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$51.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 9.57% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 7.76% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Pixelworks
PXLW
$45.7M
| $106K | ﹤0.01% |
+2,732
| New | +$118K |
|
2402
Qiagen
QGEN
$8.93B
| $106K | ﹤0.01% |
2,339
+2,150
| +1,138% | +$96.2K |
|
|
TVRD
2403
Tvardi Therapeutics
TVRD
$22.1M
| $106K | ﹤0.01% |
+173
| New | +$95.5K |
|
|
LJPC
2404
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $106K | ﹤0.01% |
+25,011
| New | +$152K |
|
2405
Apogee Enterprises
APOG
$888M
| $105K | ﹤0.01% |
+4,559
| New | +$93.2K |
|
2406
Black Diamond Therapeutics
BDTX
$116M
| $105K | ﹤0.01% |
+2,496
| New | +$91.9K |
|
2407
Cass Information Systems
CASS
$750M
| $105K | ﹤0.01% |
+2,683
| New | +$101K |
|
2408
Dine Brands
DIN
$440M
| $105K | ﹤0.01% |
+2,487
| New | +$100K |
|
|
EEX
2409
DELISTED
Emerald Holding
EEX
| $105K | ﹤0.01% |
+34,223
| New | +$81.2K |
|
2410
Essential Properties Realty Trust
EPRT
$6.71B
| $105K | ﹤0.01% |
7,046
+6,653
| +1,693% | +$91.6K |
|
2411
Manitowoc
MTW
$753M
| $105K | ﹤0.01% |
9,649
+4,701
| +95% | +$44.5K |
|
2412
Perrigo
PRGO
$1.78B
| $105K | ﹤0.01% |
1,891
-2,886
| -60% | -$152K |
|
2413
Travere Therapeutics
TVTX
$5.79B
| $105K | ﹤0.01% |
+5,125
| New | +$81.6K |
|
2414
Ultralife
ULBI
$124M
| $105K | ﹤0.01% |
14,938
+14,421
| +2,789% | +$105K |
|
2415
ProShares Ultra Real Estate
URE
$60M
| $105K | ﹤0.01% |
1,973
-6,779
| -77% | -$339K |
|
|
VBIV
2416
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $105K | ﹤0.01% |
+1,127
| New | +$62.1K |
|
|
HSKA
2417
DELISTED
Heska Corp
HSKA
| $105K | ﹤0.01% |
1,129
+388
| +52% | +$29.9K |
|
2418
Kite Realty
KRG
$5.31B
| $104K | ﹤0.01% |
+8,997
| New | +$90.4K |
|
2419
Pangaea Logistics
PANL
$496M
| $104K | ﹤0.01% |
+41,511
| New | +$90.4K |
|
2420
Smith & Wesson
SWBI
$643M
| $104K | ﹤0.01% |
+6,286
| New | +$58.4K |
|
|
SWKH
2421
DELISTED
SWK Holdings
SWKH
| $104K | ﹤0.01% |
+11,037
| New | +$109K |
|
2422
Tredegar Corp
TG
$278M
| $104K | ﹤0.01% |
+6,736
| New | +$104K |
|
2423
Unum
UNM
$14.7B
| $104K | ﹤0.01% |
+6,301
| New | +$99.4K |
|
|
HOME
2424
DELISTED
At Home Group Inc.
HOME
| $104K | ﹤0.01% |
16,070
+12,674
| +373% | +$51.9K |
|
|
TEUM
2425
DELISTED
Pareteum Corporation
TEUM
| $104K | ﹤0.01% |
167,091
+153,084
| +1,093% | +$84.4K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review
As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.
- Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
- Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
- Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
- Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
- Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
- Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.